Dobutamine recalls
Dobutamine products have been recalled 2 times, most recently on 2 Jul 2025. The recalling company is usually Pfizer. The most common reason is particulate matter.
Total recalls2since 2014
Last 12 months0reported
Class I150% of total
Ongoing1latest 2 Jul 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 50%Class II 1 50%Class III 0 0%
Why dobutamine is recalled
Companies
Product types
By year
Ongoing dobutamine recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | DOBUTamine Injection, USP, 250 mg recalled by PfizerDobutamine | Pfizer | Other | Nationwide |
All dobutamine recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | DOBUTamine Injection, USP, 250 mg recalled by PfizerDobutamine | Pfizer | Other | Nationwide |
| Drug | CLASS I | DOBUTamine Injection, USP, 250 mg per Single-dose Fliptop Vial recalledDobutamine | Hospira | Particulate Matter | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.